Diaphorina citri psyllid: psy15337

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Receptor-type tyrosine-protein phosphatase beta	Plays an important role in blood vessel remodeling and angiogenesis. Not necessary for the initial formation of blood vessels, but is essential for their maintenance and remodeling. Can induce dephosphorylation of TEK/TIE2, CDH5/VE-cadherin and KDR/VEGFR-2. Regulates angiopoietin-TIE2 signaling in endothelial cells. Acts as a negative regulator of TIE2, and controls TIE2 driven endothelial cell proliferation, which in turn affects blood vessel remodeling during embryonic development and determines blood vessel size during perinatal growth. Essential for the maintenance of endothelial cell contact integrity and for the adhesive function of VE-cadherin in endothelial cells and this requires the presence of plakoglobin.	confident	B2RU80

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0007156 [BP]	homophilic cell adhesion	probable	GO:0016337, GO:0009987, GO:0044763, GO:0007155, GO:0008150, GO:0022610, GO:0044699
GO:0003093 [BP]	regulation of glomerular filtration	probable	GO:0003073, GO:0003071, GO:0044057, GO:0050878, GO:0008015, GO:0065007, GO:0050789, GO:0008150, GO:0001977, GO:0032501, GO:0003014, GO:0051239, GO:0003013, GO:0008217, GO:0065008, GO:0044707, GO:0044699, GO:0003008
GO:0009897 [CC]	external side of plasma membrane	probable	GO:0009986, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0006950 [BP]	response to stress	probable	GO:0050896, GO:0008150
GO:0043025 [CC]	neuronal cell body	probable	GO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0010332 [BP]	response to gamma radiation	probable	GO:0008150, GO:0009314, GO:0050896, GO:0010212, GO:0009628
GO:0008013 [MF]	beta-catenin binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0005001 [MF]	transmembrane receptor protein tyrosine phosphatase activity	probable	GO:0016787, GO:0038023, GO:0016788, GO:0004725, GO:0004721, GO:0042578, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0016791, GO:0019198, GO:0003824
GO:0051209 [BP]	release of sequestered calcium ion into cytosol	probable	GO:0050801, GO:0055065, GO:0051282, GO:0051283, GO:0032844, GO:0042592, GO:0055074, GO:0050789, GO:0044699, GO:0072507, GO:0051234, GO:0072503, GO:0065007, GO:0006812, GO:0048519, GO:0051641, GO:0019725, GO:0009987, GO:0060401, GO:0060402, GO:0006875, GO:0006874, GO:0006811, GO:0006810, GO:0006816, GO:0006873, GO:0050794, GO:0044765, GO:0030001, GO:0030003, GO:0051649, GO:0055080, GO:0072511, GO:0055082, GO:0032879, GO:0051179, GO:0016482, GO:0065008, GO:0070838, GO:0046907, GO:0051480, GO:0044763, GO:0007204, GO:0048878, GO:2000021, GO:0008150
GO:0051019 [MF]	mitogen-activated protein kinase binding	probable	GO:0019899, GO:0019901, GO:0019900, GO:0003674, GO:0005488, GO:0005515
GO:0051393 [MF]	alpha-actinin binding	probable	GO:0042805, GO:0003674, GO:0005488, GO:0005515, GO:0008092
GO:0030426 [CC]	growth cone	probable	GO:0030427, GO:0044463, GO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0090090 [BP]	negative regulation of canonical Wnt receptor signaling pathway	probable	GO:0009968, GO:0008150, GO:0009966, GO:0048585, GO:0048583, GO:0048519, GO:0050794, GO:0050789, GO:0023057, GO:0030111, GO:0065007, GO:0010648, GO:0023051, GO:0048523, GO:0010646, GO:0030178, GO:0060828
GO:0045295 [MF]	gamma-catenin binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:2000026 [BP]	regulation of multicellular organismal development	probable	GO:0050793, GO:0008150, GO:0065007, GO:0050789, GO:0051239
GO:0010759 [BP]	positive regulation of macrophage chemotaxis	probable	GO:0032103, GO:0032101, GO:0048584, GO:0048583, GO:0050920, GO:0050921, GO:0050789, GO:0002687, GO:0002684, GO:0002685, GO:0002682, GO:0048518, GO:0065007, GO:0002688, GO:0030335, GO:0030334, GO:0050795, GO:0050794, GO:0071622, GO:0051270, GO:0008150, GO:0032879, GO:0051272, GO:0040012, GO:0040017, GO:0071675, GO:2000145, GO:0002690, GO:2000147, GO:0010758, GO:0048520, GO:0048522
GO:0043065 [BP]	positive regulation of apoptotic process	probable	GO:0050794, GO:0050789, GO:0048518, GO:0043067, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0031290 [BP]	retinal ganglion cell axon guidance	probable	GO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0007411, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0042330, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0006935, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0007409, GO:0048731, GO:0042221, GO:0022008, GO:0048858, GO:0040011, GO:0048699, GO:0032990, GO:0009605, GO:0050896, GO:0048856, GO:0007399, GO:0048812, GO:0044763
GO:0005829 [CC]	cytosol	probable	GO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0048008 [BP]	platelet-derived growth factor receptor signaling pathway	probable	GO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0007154, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007169, GO:0050789, GO:0044699
GO:0005925 [CC]	focal adhesion	probable	GO:0070161, GO:0005575, GO:0005912, GO:0005924, GO:0030054, GO:0030055
GO:0060076 [CC]	excitatory synapse	probable	GO:0005575, GO:0045202
GO:0090288 [BP]	negative regulation of cellular response to growth factor stimulus	probable	GO:0090287, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0043407 [BP]	negative regulation of MAP kinase activity	probable	GO:0033673, GO:0043549, GO:0019220, GO:0080090, GO:0019222, GO:0044092, GO:0048585, GO:0031324, GO:0048583, GO:0023057, GO:0043405, GO:0010648, GO:0023051, GO:0009892, GO:0071901, GO:0071900, GO:0010627, GO:0043086, GO:0043409, GO:0043408, GO:0051248, GO:0010646, GO:0010605, GO:0009968, GO:0009966, GO:0051348, GO:0051246, GO:0050789, GO:0065007, GO:0031399, GO:0048519, GO:0065009, GO:0010741, GO:0006469, GO:0045936, GO:0060255, GO:0031323, GO:0045859, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0042325, GO:0032269, GO:0042326, GO:0050790, GO:0010563, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0048523
GO:0070887 [BP]	cellular response to chemical stimulus	probable	GO:0051716, GO:0050896, GO:0009987, GO:0008150, GO:0044763, GO:0042221, GO:0044699
GO:0035335 [BP]	peptidyl-tyrosine dephosphorylation	probable	GO:0071704, GO:0044267, GO:0044260, GO:0044238, GO:0016311, GO:0006470, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0019538, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0051726 [BP]	regulation of cell cycle	probable	GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0042493 [BP]	response to drug	probable	GO:0042221, GO:0050896, GO:0008150
GO:0016790 [MF]	thiolester hydrolase activity	probable	GO:0016787, GO:0003674, GO:0016788, GO:0003824
GO:0030027 [CC]	lamellipodium	probable	GO:0005575, GO:0042995, GO:0044464, GO:0031252, GO:0005623
GO:0007267 [BP]	cell-cell signaling	probable	GO:0044700, GO:0009987, GO:0008150, GO:0023052, GO:0007154, GO:0044763, GO:0044699
GO:0050918 [BP]	positive chemotaxis	probable	GO:0040011, GO:0006935, GO:0009605, GO:0050896, GO:0042330, GO:0008150, GO:0042221
GO:0043197 [CC]	dendritic spine	probable	GO:0044309, GO:0044463, GO:0044464, GO:0030425, GO:0005575, GO:0097458, GO:0005623, GO:0043005, GO:0042995
GO:0043116 [BP]	negative regulation of vascular permeability	probable	GO:0032501, GO:0044707, GO:0008015, GO:0003013, GO:0065007, GO:0003018, GO:0008150, GO:0065008, GO:0043114, GO:0044699, GO:0003008
GO:0032587 [CC]	ruffle membrane	probable	GO:0001726, GO:0016020, GO:0031256, GO:0044463, GO:0031253, GO:0031252, GO:0005623, GO:0044464, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0042995, GO:0044459
GO:0048514 [BP]	blood vessel morphogenesis	probable	GO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0005158 [MF]	insulin receptor binding	probable	GO:0032403, GO:0005102, GO:0003674, GO:0005488, GO:0005515
GO:0002376 [BP]	immune system process	probable	GO:0008150
GO:0022603 [BP]	regulation of anatomical structure morphogenesis	probable	GO:0050793, GO:0008150, GO:0065007, GO:0050789
GO:0048646 [BP]	anatomical structure formation involved in morphogenesis	probable	GO:0032502, GO:0009653, GO:0008150, GO:0048856
GO:0001772 [CC]	immunological synapse	probable	GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0042301 [MF]	phosphate ion binding	probable	GO:0043168, GO:0003674, GO:0005488, GO:0043167
GO:0060041 [BP]	retina development in camera-type eye	probable	GO:0032502, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0048731, GO:0008150, GO:0043010, GO:0007275, GO:0044699
GO:0005730 [CC]	nucleolus	probable	GO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0042803 [MF]	protein homodimerization activity	probable	GO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0070097 [MF]	delta-catenin binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0051251 [BP]	positive regulation of lymphocyte activation	probable	GO:0051249, GO:0050865, GO:0050867, GO:0050794, GO:0008150, GO:0002694, GO:0002684, GO:0002696, GO:0002682, GO:0048518, GO:0065007, GO:0050789, GO:0048522
GO:0005161 [MF]	platelet-derived growth factor receptor binding	probable	GO:0005102, GO:0003674, GO:0005488, GO:0005515, GO:0070851
GO:0030336 [BP]	negative regulation of cell migration	probable	GO:0040013, GO:0051270, GO:0065007, GO:0051271, GO:0040012, GO:0008150, GO:0030334, GO:2000145, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0030424 [CC]	axon	probable	GO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0051898 [BP]	negative regulation of protein kinase B signaling cascade	probable	GO:0009968, GO:0050794, GO:0009966, GO:0048585, GO:0048583, GO:0010741, GO:0050789, GO:0023057, GO:0065007, GO:0010648, GO:0008150, GO:0023051, GO:0048519, GO:0010646, GO:0010627, GO:0051896, GO:0048523
GO:0051897 [BP]	positive regulation of protein kinase B signaling cascade	probable	GO:0023051, GO:0009966, GO:0010740, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0050789, GO:0065007, GO:0009967, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0010627, GO:0051896, GO:0048522
GO:0051894 [BP]	positive regulation of focal adhesion assembly	probable	GO:0051130, GO:1901888, GO:1901890, GO:0010811, GO:0030155, GO:0001954, GO:0001952, GO:0090109, GO:0008150, GO:0044087, GO:0010810, GO:0048518, GO:0051893, GO:0065007, GO:0045785, GO:0051128, GO:0050789, GO:0050794, GO:0048522
GO:0050680 [BP]	negative regulation of epithelial cell proliferation	probable	GO:0042127, GO:0008285, GO:0050678, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0001960 [BP]	negative regulation of cytokine-mediated signaling pathway	probable	GO:0009968, GO:0001959, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0060761, GO:0048519, GO:0010646, GO:0050789, GO:0048523, GO:0060759
GO:0048471 [CC]	perinuclear region of cytoplasm	probable	GO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:1900076 [BP]	regulation of cellular response to insulin stimulus	probable	GO:0008150, GO:0065007, GO:0048583, GO:0050789, GO:0050794
GO:0043395 [MF]	heparan sulfate proteoglycan binding	probable	GO:0043168, GO:1901681, GO:0043167, GO:0043394, GO:0003674, GO:0005488, GO:0005515, GO:0001948
GO:0005887 [CC]	integral to plasma membrane	probable	GO:0031226, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459, GO:0031224
GO:0005739 [CC]	mitochondrion	probable	GO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0010642 [BP]	negative regulation of platelet-derived growth factor receptor signaling pathway	probable	GO:0009968, GO:0008150, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0050789, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0010640, GO:0048523
GO:0005768 [CC]	endosome	probable	GO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0045597 [BP]	positive regulation of cell differentiation	probable	GO:0051094, GO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0008201 [MF]	heparin binding	probable	GO:0043168, GO:1901681, GO:0097367, GO:0043167, GO:0005539, GO:0003674, GO:0005488
GO:0045294 [MF]	alpha-catenin binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0045296 [MF]	cadherin binding	probable	GO:0050839, GO:0003674, GO:0005488, GO:0005515
GO:0030308 [BP]	negative regulation of cell growth	probable	GO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0017147 [MF]	Wnt-protein binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0042059 [BP]	negative regulation of epidermal growth factor receptor signaling pathway	probable	GO:0010646, GO:0009968, GO:0050794, GO:0009966, GO:0048585, GO:0048583, GO:0042058, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:1901184, GO:1901185, GO:0050789, GO:0048523
GO:0016328 [CC]	lateral plasma membrane	probable	GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0016324 [CC]	apical plasma membrane	probable	GO:0045177, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0016477 [BP]	cell migration	probable	GO:0040011, GO:0048870, GO:0009987, GO:0006928, GO:0051674, GO:0044763, GO:0008150, GO:0051179, GO:0044699
GO:0005913 [CC]	cell-cell adherens junction	probable	GO:0005575, GO:0030054, GO:0070161, GO:0005912, GO:0005911

Prediction of Enzyme Commission Number

No confident prediction of EC number!

Spatial Structural Prediction